No Data
[Brokerage Focus] China Securities Co.,Ltd. has raised the Target Price for INNOVENT BIO (01801) to HK$71.92, indicating that its layout in the oncology sector has begun to take shape.
Jingu Financial News | China Securities Co., Ltd. issued a research report indicating that INNOVENT BIO (01801) updated the data on IBI343 (CLDN18.2ADC) for pancreatic cancer at the latest ESMO Asia conference. The ORR for 43 patients with second-line and above pancreatic cancer (60.5% of patients are third-line and above) is 32.6%, cORR is 23.6%, cDCR is 81.4%, and mPFS is 5.3 months, which exceeds the mPFS of the existing third-line therapies (about 2 months) and also surpasses the mPFS of existing second-line therapies (2-3.5 months). The firm believes that
Hong Kong stock concept tracking | Eli Lilly and Co will invest 3 billion USD to expand its production base in the usa, as global demand for weight loss drugs exceeds supply (including concept stocks).
Eli Lilly and Co (LLY.US) will invest 3 billion dollars to expand its production base in the USA.
Bearish landing? Hong Kong stocks in the pharmaceutical sector collectively strengthen with wuxi apptec rising over 8%.
① How much impact did the biological safety legislation have on domestic pharmaceutical stocks previously? ② How do industry insiders view the subsequent development of the biological legislation?
Hong Kong stock concept tracking | The biocontrol bill was not included in the latest version of NDAA. Institutions are bullish on the bottom opportunities in the CXO sector (with concept stocks attached).
On December 7, 2024, local time in the USA, the US Congressional Armed Services Committees in both the House and the Senate released the final agreement text of the 2025 National Defense Authorization Act (NDAA), which incorporates proposals from both chambers.
Honkong stock market movement | CRO concept stocks collectively opened higher as the bioprotective legislation was not included in the final version of the NDAA by the U.S. Senate and House of Representatives.
CRO concept stocks opened higher collectively. As of the time of writing, wuxi bio (02269) increased by 13.03%, trading at 19.6 Hong Kong dollars; wuxi apptec (02359) rose by 11.72%, trading at 61 Hong Kong dollars; pharmaron (03759) climbed by 9.14%, trading at 16 Hong Kong dollars.
Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients With Advanced Pancreatic Cancer at the ESMO Asia Congress 2024
SAN FRANCISCO and SUZHOU, China, Dec. 9, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and
